Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes Body Care Children Complications Defeat Diabetes Foundation Drugs    » ACE Inhibitor    » Actos    » Alternative Medicine    » Aspirin    » Avandia    » Byetta    » Drugs    » Exenatide    » Glargine    » Glucophage    » Insulin    » Januvia    » Lantus    » Liraglutide    » Metformin    » Recall    » Research    » Rosiglitazone    » Self-Management    » Statins    » Sulfonylureas    » Victoza Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

Drugs » Insulin

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

Intensified Treatment with Basal Insulin Improves Control and Weight Loss Posted: Saturday, September 24, 2011

Adding insulin detemir to a treatment regimen of metformin and liraglutide improved glycemic control and led to sustained weight loss for up to 52 weeks in patients with type 2 diabetes.

EASD: Outpatient Test Discriminates MODY from Type 1 Diabetes Posted: Saturday, September 24, 2011

A measure of the postprandial ratio of urinary C-peptide to creatinine (UCPCR) can distinguish maturity-onset diabetes of the young (MODY) from type 1 diabetes mellitus, allowing some children who would otherwise be treated with insulin to receive oral antidiabetic agents alone.

Insulin Pumps Can Increase or Decrease Insulin Dose when Flying Posted: Tuesday, August 16, 2011

Changes in cabin pressure during flights may cause insulin pumps to deliver too much or too little of the medication -- possibly putting sensitive diabetes patients at risk, researchers report.

Is Inhaled Insulin Closer to Reality? Posted: Monday, July 11, 2011

New data on the inhalable insulin product Technosphere Insulin Afrezza, from MannKind Corp., indicate that the treatment confers no discernible risk for increased cardiovascular (CV) events, while another study examined patient satisfaction with this type of drug.

Potential New Non-Insulin Treatment for Type 1 Diabetes Posted: Tuesday, April 05, 2011

Researchers have discovered a hormone pathway that potentially could lead to new ways of treating Type 1 diabetes independent of insulin.

Study Finds Three Times-a-Week Insulin Improves Glucose Levels Posted: Sunday, March 20, 2011

An alternate form of insulin that is longer lasting may be approved in upcoming years.

Carb Counting vs. Glycemic Load to Determine Insulin Bolus? Posted: Sunday, March 20, 2011

How many carbs you eat might be less important for your blood sugar than your food's glycemic load.

A 495% Increase in Annual Incidence of Unintentional Therapeutic Errors Involving Insulin Posted: Sunday, February 13, 2011

Unintentional therapeutic errors involving insulin occurred primarily in adults more than 40 years old (73%) and occurred between the hours of 6-12PM.

Effects of Insulin on Brain Glucose Metabolism in Impaired Glucose Tolerance Posted: Sunday, February 13, 2011

Insulin stimulates brain glucose metabolism at physiological postprandial levels in patients with impaired glucose tolerance but not in healthy subjects.

New Once Daily Insulin Degludec Reduces Hypoglycemia Posted: Sunday, February 13, 2011

In Type 1 diabetes patients, insulin degludec -- an ultra-long-acting basal insulin -- controlled blood sugar levels as well as insulin glargine but with less hypoglycemia.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.